February 2017
J7320 replaces Q9980 when billing for Hyaluronan or derivative, GenVisc 850
The Centers for Medicare & Medicaid Services has established a permanent procedure code for Hyaluronan or derivative, GenVisc 850, effective Jan. 1, 2017.
All services from Jan. 1, 2016, through Dec. 31, 2016, will continue to be reported with code Q9980. All services performed on and after Jan. 1, 2017, must be reported with J7320.
Hyaluronan or derivative, GenVisc 850, continues to be covered as establisted on Jan. 1, 2016.
Pharmacy doesn’t require preauthorization of this drug. |